Dr Sarah Curtis

2021

• Richter, F. C., Alrubayyi, A., Teijeira Crespo, A. and Hulin-Curtis, S. 2021. Impact of obesity and SARS-CoV-2 infection: implications for host defence - a living review. Oxford Open Immunology 2(1), article number: iqab001. (10.1093/oxfimm/iqab001)

2020

• Hulin-Curtis, S. et al. 2020. Identification of folate receptor α (FRα) binding oligopeptides and their evaluation for targeted virotherapy applications. Cancer Gene Therapy 27, pp. 785-798. (10.1038/s41417-019-0156-0)
• Greenshields-Watson, A. et al. 2020. CD4 + T cells recognize conserved influenza A epitopes through shared patterns of V-Gene usage and complementary biochemical features. Cell Reports 32(2), article number: 107885. (10.1016/j.celrep.2020.107885)
• Scurr, M. J. et al. 2020. Cancer antigen discovery is enabled by RNA-sequencing of highly purified malignant and non-malignant cells. Clinical Cancer Research (10.1158/1078-0432.CCR-19-3087)

2018

• Hulin-Curtis, S., Davies, J. A., Jones, R., Hudson, E., Hanna, L., Chester, J. D. and Parker, A. L. 2018. Histone deacetylase inhibitor trichostatin A sensitises cisplatin-resistant ovarian cancer cells to oncolytic adenovirus. Oncotarget 9(41), pp. 26328-26341. (10.18632/oncotarget.25242)

2017

• Hulin-Curtis, S., Williams, H., Wadey, K. S., Sala-Newby, G. B. and George, S. J. 2017. Targeting Wnt/b-catenin activated cells with dominant-negative N-cadherin to reduce neointima formation. Molecular Therapy - Methods & Clinical Development 5, pp. 191-199. (10.1016/j.omtm.2017.04.009)

2016

• Hulin-Curtis, S., Uusi-Kerttula, H., Jones, R., Hanna, L., Chester, J. D. and Parker, A. L. 2016. Evaluation of CD46 re-targeted adenoviral vectors for clinical ovarian cancer intraperitoneal therapy. Cancer Gene Therapy 23(7), pp. 229-234. (10.1038/cgt.2016.22)
• Williams, H., Mill, C. A. E., Monk, B. A., Hulin-Curtis, S., Johnson, J. and George, S. J. 2016. Wnt2 and WISP-1/CCN4 induce intimal thickening via promotion of smooth muscle cell migration. Arteriosclerosis Thrombosis and Vascular Biology 36(7), pp. 1417-1424. (10.1161/ATVBAHA.116.307626)
• Uusi-Kerttula, H., Davies, J., Curtis, S., Chester, J. and Parker, A. 2016. Pseudotyped αvβ6 integrin-targeted adenovirus vectors for ovarian cancer therapies. Oncotarget 7(19), pp. 27926-27937. (10.18632/oncotarget.8545)

2015

• Uusi-Kerttula, H., Hulin-Curtis, S., Davies, J. A. and Parker, A. L. 2015. Oncolytic adenovirus: strategies and insights for vector design and immuno-oncolytic applications. Viruses 7(11), pp. 6009-6042. (10.3390/v7112923)
• Hulin-Curtis, S., Uusi-Kerttula, H., Jones, R., Baker, A., Chester, J. D. and Parker, A. L. 2015. Evaluation of CD46 utilising adenoviral vectors for clinical ovarian cancer applications [Abstract]. Human Gene Therapy 26(9), pp. A33-A34., article number: PO72. (10.1089/hum.2015.29005.abstracts)

2014

• Galea, G. L., Meakin, L. B., Williams, C. M., Hulin-Curtis, S., Lanyon, L. E., Poole, A. W. and Price, J. S. 2014. Protein kinase Cα (PKCα) regulates bone architecture and osteoblast activity. Journal of Biological Chemistry 289(37), pp. 25509-25522. (10.1074/jbc.M114.580365)
• Tully, L. J., Murphy, A. M., Smith, R. K. W., Hulin-Curtis, S., Verheyen, K. L. P. and Price, J. S. 2014. Polymorphisms inTNCandCOL5A1genes are associated with risk of superficial digital flexor tendinopathy in National Hunt thoroughbred racehorses. Equine Veterinary Journal 46(3), pp. 289-293. (10.1111/evj.12134)
• Williams, H., Mill, C. A., Hulin-Curtis, S., Johnson, J. L. and George, S. J. 2014. Wnt inducible soluble protein 1 (WISP-1) promotes VSMC migration and intimal thickening. Atherosclerosis 232(2), pp. e2. (10.1016/j.atherosclerosis.2013.11.004)

2013

• Hulin-Curtis, S., Bidwell, J. L. and Perry, M. J. 2013. Association between CCL2 haplotypes and knee osteoarthritis. International Journal of Immunogenetics 40(4), pp. 280-283. (10.1111/iji.12015)
• Hulin-Curtis, S., Sharif, M., Bidwell, J. L. and Perry, M. J. 2013. Evaluation of NFKB1A variants in patients with knee osteoarthritis. International Journal of Immunogenetics 40(4), pp. 272-279. (10.1111/iji.12020)

2012

• Hulin-Curtis, S., Bidwell, J. L. and Perry, M. J. 2012. Tumour necrosis factor receptor superfamily member 11B polymorphisms and association with knee osteoarthritis in women. International Journal of Immunogenetics 39(3), pp. 207-209. (10.1111/j.1744-313X.2012.01083.x)
• Hulin-Curtis, S. 2012. Evaluation of IL18 and IL18R1 polymorphisms: genetic susceptibility to knee osteoarthritis. International Journal of Immunogenetics 39(2), pp. 106-109. (10.1111/j.1744-313X.2011.01060.x)

2010

• Hulin-Curtis, S., Petit, D., Figg, W. D., Hsing, A. W. and Reichardt, J. K. 2010. Finasteride metabolism and pharmacogenetics: new approaches to personalized prevention of prostate cancer. Future Oncology 6(12), pp. 1897-1913. (10.2217/fon.10.149)

2000

• Miles, C. A., Sionkowska, A., Hulin, S. L., Sims, T. J., Avery, N. C. and Bailey, A. J. 2000. Identification of an intermediate state in the helix-coil degradation of collagen by ultraviolet light. Journal of Biological Chemistry 275(42), pp. 33014-33020. (10.1074/jbc.M002346200)